Compositions containing Nicorandil, preparation method and use

Details for Australian Patent Application No. 2005271131 (hide)

Owner Aventis Pharma S.A.

Inventors Bonhomme, Thierry; Nocent, Mathieu

Agent A J Park

Pub. Number AU-B-2005271131

PCT Pub. Number WO2006/016040

Priority 0407590 08.07.04 FR

Filing date 5 July 2005

Wipo publication date 16 February 2006

Acceptance publication date 29 April 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/016040 Priority application(s): WO2006/016040

29 April 2010 Application Accepted

  Published as AU-B-2005271131

26 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271134-Martensitic stainless steel for moulds and injection mould frames

2005271130-2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof